• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of stable and regulated gene expression system for gene therapy

Research Project

Project/Area Number 12672145
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Biological pharmacy
Research InstitutionNational Institute of Health Sciences

Principal Investigator

HAYAKAWA Takao  National Institute of Health Sciences, Division of Biological Chemistry and Biologicals, Division Director, 生物薬品部, 部長 (50124392)

Co-Investigator(Kenkyū-buntansha) MIZUGUCHI Hiroyuki  National Institute of Health Sciences, Division of Biological Chemistry and Biologicals, Researcher, 生物薬品部, 研究員 (50311387)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2000: ¥2,100,000 (Direct Cost: ¥2,100,000)
Keywordsgene therapy / adenovirus vector / adeno-associated virus vector / gene requlation / plasmid vector
Research Abstract

In basic genetic research, control oftransgene expression in mammalian cells should be desirable forgene therapyand the studyofgene function. Permanentand higher levels of gene expression should be also preferable. The expression levels of the introduced gene depend mostly on the strength oftranscriptional regulatory elements and the transduction efficiency of the gene transfer vector.
In this study, we investigated the effective combination of commonly-used regulatory elements, such as the promoter/enhancer, intron, and polyadenylation signal (P(A)) sequence by constructing a series of plasmids and recombinant adenovirus vectors that differed only in the particular sequence element being evaluated. Of the several promoter/enhancers that were tested, hybrid CA promoter/enhancer containing human cytomegalovirus immediate-early 1 gene (CMV) enhancer and chicken β-actin promoterwith the β-actin intron sequence, and the improved CMV promoter/enhancer containing the largest intron of CMV(int … More ron A) produced the highest levels of expression both in vitro and in vivo. P(A)sequences were found to have significant effects on transgene expression. These comparative analyses could provide a systematic reference for the development of vector construction for gene therapy, vaccine development, and gene transfer experiments.
Next, we examined the stable gene expression using the plasmids containing the components derived from adeno-associated virus (AAV). We examined the efficiency of colony formation of the neomycin resistant cells which were transfected with the plasmid containing neomycin resistant gene franked with AAVITR (inverted terminal repeat). Number of colony of neomycin resistant cells transfected with the plasmid with AAVITR and Rep78(AAVderived proteinj-expressing plasmid was much higher than that with the plasmid without AAVITRand Rep78expressing plasmid, suggesting that Rep78 protein assisted the integration of the foreing gene intothe host genome. We are now applying this techiniqes intothe integration of the genomic foreign DNA into the host genome. This system using genomic DNA could get stable and regulated gene expression. Less

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Xu Z.L., Mizuguchi H., Ishii-Watabe A., Uchida E., Mayumi T., Hayakawa T: "Optimization of transcriptional regulatory elements for constructing plasmid vectors"Gene. 272. 149-156 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] H.Mizuguchi, T.Hayakawa: "Characteristics of adenovirus-mediated tetracycline controllable expression system"Biochim. Biophys. Acta. 1568. 21-29 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] H.Mizuguchi, M.A.Kay, T.Hayakawa: "In vitro ligation-based cloning of foreign DNAs into the E3 as well as E1 deletion region for generation of recombinant adenovirus vector"Bio Techniques. 30. 1112-1116 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Xu Z.L., Mizuguchi H., Ishii-Watabe A., Uchida E., Mayumi T., Hayakawa T: "Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector"J. Control. Rel.. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] H.Mizuguchi, Z.L.Xu, A.Ishii-Watabe, E.Uchida, T.Hayakawa: "IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector"Mol. Ther.. 1. 376-382 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] H.Mizuguchi, T.Hosono, T.Hayakawa: "Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells"FEBS Letter. 472. 173-178 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Xu Z.L et al: "Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector"J. Control. Rel. (in Press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Xu Z.L et al: "Optimization of transcriptional regulatory elements for constructing plasmid vectors"Gene. 272. 149-156 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mizuguchi H. et al: "Characteristics of adenovirus-mediated tetracycline controllable expression system"Biochim. Biophys. Acta. 1568. 21-29 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mizuguchi H. et al: "In vitro ligation-based cloning of foreign DMAs into the E3 as well as E1 deletion region for generation of recombinant adenovirus vector"Bio Techniques. 30. 1112-1116 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mizuguchi H. et al: "Long-Term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells"FEBS Letter. 472. 173-178 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Mizuguchi H. et al: "IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector"Mol. Ther.. 1. 376-382 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Xu Z., Mizuguchi H., Ishii-Watabe A., Uchida E., Mayumi T., Hayakawa T: "Optimization of transcriptional regulatory elements for constructing plasmid vectors"Gene. 272. 149-156 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] H.Mizuguchi, T.Hayakawa: "Characteristics of adenovirus-mediated tetracycline controllable expression system"Biochim. Biophys. Acda. 1568. 21-29 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] H.Mizuguchi, M.A.Kay, T.Hayakawa: "In vitro ligation-based cloning of foreign DNAs into the E3 as well as E1 deletion region for generation of recombinant adenovirus vector"Bio Techniques. 30. 1112-1116 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Xu Z., Mizuguchi H., Ishii-Watabe A., Uchida E., Mayumi T., Hayakawa T: "Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector"J. Control. Rel.. (in press).

    • Related Report
      2001 Annual Research Report
  • [Publications] H.Mizuguchi,N.Koizumi,T.Hosono,N.Utoguchi,Y.Watanabe,M.A.Kay,T.Hayakawa.: "A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob"Gene Ther.. (in press).

    • Related Report
      2000 Annual Research Report
  • [Publications] N.Okada,Y.Tsukada,S.Nakagawa,H.Mizuguchi,K.Mori,T.Saito,T.Fujita,A.Yamamoto,T.Hayakawa,T.Mayumi.: "Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors."Biochem.Biophys.Res.Commun.. (in press).

    • Related Report
      2000 Annual Research Report
  • [Publications] 水口裕之,早川堯夫: "アデノウイルスベクター作製技術と次世代ベクターへの応用-ファイバーミュータントアデノウイルスベクターを中心として-"日本臨床. 58. 1544-1553 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] H.Mizuguchi,Z.Xu,A.Ishii-Watabe,E.Uchida,T.Hayakawa: "IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector."Mol.Ther.. 1. 376-382 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Y.Nagayama,E.Nishiara,H.Namba,H.Yokoi,M.Hasegawa,H.Mizuguchi,T.Hayakawa,H.Hamada,S.Yamashita,M.Niwa.: "Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated cre/loxP system."Cancer Gene Ther.. 8. 36-44 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] H.Mizuguchi,T.Hosono,,T.Hayakawa: "Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells."FEBS Letter. 472. 173-178 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi